Abstract

Fenbendazole (FBZ) is an anthelmintic recently approved to treat and control nematode infections in growing turkeys. When administered to growing turkeys there are no detrimental side effects. However, when we used FBZ to treat nematodes in mature breeder toms, we observed a decrease in semen quality and a subsequent precipitous decline in fertility to less than 20% within 6 wk of administration. An experiment was designed to determine the impact of FBZ administration on aspects of spermatogenesis and semen quality. We discovered that although sperm viability and concentration was not significantly affected by FBZ, this drug significantly reduced sperm mobility. However, normal mobility resumed within 6 wk after FBZ administration. Fenbendazole binds to tubulin and interferes with microtubule assembly. Based on testes histology and the immunocytochemical localization of tubulin in spermatids and mature sperm, FBZ had no affect on any aspect of spermatogenesis. We suggest that FBZ may be affecting sperm mobility by some molecular alteration of the sperm tail axoneme or midpiece, both of which are tubulin-containing structures. If a breeding flock of toms become infected with nematode parasites, a flock manager has the following options: do not treat the toms, find an alternative to FBZ, treat the toms with FBZ and increase the sperm number and frequency of artificial inseminations, or treat the toms with FBZ and secure semen from an uninfected tom flock.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call